Method and Formulation for Improving Roflumilast Skin Penetration Lag Time | Patent Publication Number 20230338275

US 20230338275 A1

Patent Number-

Application Number18345732

Filled DateJun 30, 2023

Priority DateJun 4, 2018

Publication DateOct 26, 2023

Original AssigneeArcutis Biotherapeutics Inc.

Current AssigneeArcutis Biotherapeutics Inc.

Inventor/ApplicantsDavid W. OSBORNE

See the invalidated claims, subscribe to our Concierge Program.

View Concierge Program

Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Check our Latest Report Purchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.